osimertinib ipilimumab in egfr-mutated nsclc
Published 3 years ago • 1.1K plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
2:06
continued use of osimertinib reduces cns metastasis in egfr mutant lung cancer
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
0:55
osimertinib for egfr-mutant lung cancer
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
3:17
phase iii mariposa: amivantamab lazertinib vs osimertinib in egfr-mutated nsclc
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
2:11
dr. low on osimertinib versus dacomitinib in egfr-mutant nsclc
-
3:54
teslisotuzumab vedotin and osimertinib for egfr-mutant, c-met-overexpressing nsclc